Search research articles
Contact Us
Filters
Showing results (91-100 of 101) with videos related to
Page
of 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 7, 2018
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2019
Reply to Cheng and Chuang
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
The Journal of Antimicrobial Chemotherapy
|
August 14, 2023
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant
William C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2018
Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses
Xiqi Li, Cesar A Arias, Samuel L Aitken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2017
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
Jose M Munita, Samuel L Aitken, William R Miller, et al.
Mayo Clinic Proceedings
|
August 31, 2020
Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
Teny M John, Alexandre E Malek, Victor E Mulanovich, et al.
Jac-Antimicrobial Resistance
|
January 5, 2023
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 27, 2026
A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needs
Elizabeth B Hirsch, David A Mott, Aaron M Gilson, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Treated With Ceftolozane/Tazobactam
Olga Rodríguez-Núñez, Leonor Periañez-Parraga, Antonio Oliver, et al.
Open Forum Infectious Diseases
|
February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
German A Contreras, Jose M Munita, Shelby Simar, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 101) with videos related to
Sort By:
Page
of 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 7, 2018
Pharmacodynamic Analysis of Daptomycin-treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 5, 2019
Reply to Cheng and Chuang
Lindsay M Avery, Joseph L Kuti, Maja Weisser, et al.
The Journal of Antimicrobial Chemotherapy
|
August 14, 2023
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant
William C Shropshire, Bradley T Endres, Jovan Borjan, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 17, 2018
Clonal Emergence of Invasive Multidrug-Resistant Staphylococcus epidermidis Deconvoluted via a Combination of Whole-Genome Sequencing and Microbiome Analyses
Xiqi Li, Cesar A Arias, Samuel L Aitken, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
March 23, 2017
Multicenter Evaluation of Ceftolozane/Tazobactam for Serious Infections Caused by Carbapenem-Resistant Pseudomonas aeruginosa
Jose M Munita, Samuel L Aitken, William R Miller, et al.
Mayo Clinic Proceedings
|
August 31, 2020
Migratory Pulmonary Infiltrates in a Patient With COVID-19 Infection and the Role of Corticosteroids
Teny M John, Alexandre E Malek, Victor E Mulanovich, et al.
Jac-Antimicrobial Resistance
|
January 5, 2023
Clinical characteristics, microbiology and outcomes of a cohort of patients treated with ceftolozane/tazobactam in acute care inpatient facilities, Houston, Texas, USA
Truc T Tran, Nicolo L Cabrera, Anne J Gonzales-Luna, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
April 27, 2026
A national survey of the infectious diseases and antimicrobial stewardship pharmacist workforce in the United States: work settings, characteristics, employment activities, resources and needs
Elizabeth B Hirsch, David A Mott, Aaron M Gilson, et al.
Open Forum Infectious Diseases
|
October 30, 2019
Higher MICs (>2 mg/L) Predict 30-Day Mortality in Patients With Lower Respiratory Tract Infections Caused by Multidrug- and Extensively Drug-Resistant <i>Pseudomonas aeruginosa</i> Treated With Ceftolozane/Tazobactam
Olga Rodríguez-Núñez, Leonor Periañez-Parraga, Antonio Oliver, et al.
Open Forum Infectious Diseases
|
February 14, 2022
Contemporary Clinical and Molecular Epidemiology of Vancomycin-Resistant Enterococcal Bacteremia: A Prospective Multicenter Cohort Study (VENOUS I)
German A Contreras, Jose M Munita, Shelby Simar, et al.
Page
of 11